uric acid has been researched along with Atherosclerosis in 142 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The European Lacidipine Study on Atherosclerosis (ELSA) was a randomized, double-blind, multicenter trial comparing the effects of a 4-year treatment with either lacidipine or atenolol on progression of carotid atherosclerosis in patients with moderate hypertension." | 9.30 | Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. ( Bombelli, M; Cuspidi, C; Facchetti, R; Grassi, G; Macchiarulo, M; Maggiolini, D; Mancia, G; Parati, G, 2019) |
| "The aim of this study was to investigate the long-term effective control of serum uric acid by allopurinol on the carotid intima-media thickness (IMT) in patients with type 2 diabetes (T2DM) and asymptomatic hyperuricemia (HUA)." | 9.20 | The Effects of Allopurinol on the Carotid Intima-media Thickness in Patients with Type 2 Diabetes and Asymptomatic Hyperuricemia: A Three-year Randomized Parallel-controlled Study. ( Chen, Y; Liu, P; Wang, D; Wang, H; Wang, Y; Zhang, F, 2015) |
| " Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases." | 9.12 | Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis. ( Kimura, Y; Kono, H; Tsukui, D, 2021) |
| "The mechanisms of hyperhomocysteinemia (HHcy) and hyperuricemia (HUA) that promote atherosclerosis were seldom explored and always indefinite." | 8.95 | Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis. ( Chen, H; Chen, J; Gu, Y; Liu, N; Yang, K; Zhao, J, 2017) |
| "The relationship between elevated serum uric acid level and metabolic syndrome (MS) has been debated." | 8.90 | Association of serum uric acid and metabolic syndrome in type 2 diabetes. ( Bonakdaran, S; Kharaqani, B, 2014) |
| " Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging." | 8.12 | Increased Impact of Serum Uric Acid on Arterial Stiffness and Atherosclerosis in Females. ( Dohi, Y; Iwase, M; Nagami, T; Ohte, N; Seo, Y; Sugiura, T; Suzuki, K; Takagi, Y; Takase, H; Tomiishi, T; Yokochi, T; Yoshikane, N, 2022) |
| "Uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) are positively and negatively associated with atherosclerosis, respectively." | 8.12 | Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis. ( Dong, H; Hu, X; Li, G; Li, W; Liu, J; Wang, C; Zhou, Y, 2022) |
| "The association between serum uric acid (UA) and atherosclerosis in old people is controversial." | 8.02 | Association between uric acid and atherosclerosis in community-dwelling older people: The SONIC study. ( Akagi, Y; Akasaka, H; Arai, Y; Godai, K; Gondo, Y; Ikebe, K; Ishizaki, T; Kabayama, M; Kamide, K; Kiyoshige, E; Masui, Y; Rakugi, H; Sekiguchi, T; Sugimoto, K; Takami, Y; Takeya, Y; Tanaka, K; Yamamoto, K; Yasumoto, S, 2021) |
| "We aimed to reveal the relationship of serum uric acid (SUA) with monocyte-high-density lipoprotein ratio (MHR) and other inflammatory markers in acne patients before and after isotretinoin treatment." | 8.02 | Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin. ( Metin, N; Turan, Ç, 2021) |
| "Uric acid is supposed but not yet determined to be associated with atherosclerosis." | 7.96 | Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation. ( Hosoyamada, M; Kimura, Y; Kono, H; Onda, A; Tsukui, D; Yanagida, T, 2020) |
| "Elevated serum uric acid (SUA) is associated with cardiovascular risk factors, which often contribute to dementia and dementia-like morbidity, yet several cross-sectional studies have shown protective associations with cognition, which would be consistent with other work showing benefits of elevated SUA through its antioxidant properties." | 7.96 | Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort. ( Alam, AB; Alonso, A; Power, MC; West, NA; Wu, A, 2020) |
| "The study aimed to determine the relationship among serum uric acid and metabolic syndrome and atherosclerosis, by means of carotid intima media-thickness, in a cohort of 811 otherwise healthy overweight/obese subjects, without overt atherosclerosis not using any kind of drug." | 7.88 | Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First? ( Caccavo, D; Carbonara, R; Ciccone, MM; Cortese, AM; Cortese, F; De Pergola, G; Masiello, M; Meliota, G; Silvestris, F; Termine, G, 2018) |
| "Allantoin is the main product of uric acid oxidation and was found to be augmented in atherosclerotic plaque in human autopsy and in animal models of atherosclerosis." | 7.88 | Allantoin as an independent marker associated with carotid intima-media thickness in subclinical atherosclerosis. ( Benseãor, IM; Lotufo, PA; Meotti, FC; Nascimento, KP; Santana, MS, 2018) |
| "This paper aims to evaluate the association between serum uric acid (SUA) levels, arterial hypertension (HT) prevalence, blood pressure values control, kidney function and intima media thickness (IMT), as a surrogate marker of early atherosclerosis, in a representative group of Romanian adult population." | 7.88 | Serum uric acid and arterial hypertension-Data from Sephar III survey. ( Buzas, R; Dorobantu, M; Ivan, V; Lighezan, D; Tautu, OF, 2018) |
| "Aim To determine the relationship of homocysteine (HCY), uric acid (UA) and C-reactive protein (CRP) in serum of patients with acute myocardial infarction (AMI) prior to application of percutaneous coronary intervention (PCI) and their level of correlation in serum of patients with normal and elevated CRP (predictor of worse cardiovascular outcomes)." | 7.88 | A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. ( Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M, 2018) |
| "Uric acid is a molecule that is known to act as a natural antioxidant in acute oxidative stress conditions such as acute ischemic stroke (AIS)." | 7.88 | Can high uric acid levels be an independent risk factor for acute ischemic stroke due to large-artery atherosclerosis? ( Acar, AB; Acar, T; Gül, SS; Güzey Aras, Y, 2018) |
| "We indicated that uric acid, AIP, and proteinuria are closely related." | 7.88 | Relationship Between Uric Acid, Proteinuria, and Atherogenic Index of Plasma in Renal Transplant Patients. ( Biyik, Z; Guney, I, 2018) |
| " Whether gout, the most common rheumatologic inflammatory arthritis, or its cause, elevated serum uric acid (SUA), is associated with VTE incidence is unknown." | 7.83 | Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. ( Folsom, AR; Kubota, Y; McAdams-DeMarco, M, 2016) |
| "Serum uric acid (SUA) is associated with many cardiovascular risk factors such as hypertension (HTN) and metabolic syndrome (MetS)." | 7.81 | Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. ( Bao, YQ; Dong, XH; Jia, WP; Li, LX; Li, MF; Li, TT; Shen, J; Zhang, R, 2015) |
| "The aim of this study was to examine the association between uric acid (UA) level during pregnancy and future maternal hospitalization for atherosclerotic-related morbidity." | 7.81 | High Uric Acid Levels During Pregnancy Linked to Increased Risk for Future Atherosclerotic-Related Hospitalization. ( Sergienko, R; Sheiner, E; Shoham-Vardi, I; Wolak, T, 2015) |
| "Male rabbits (n = 48) were divided into control, hyperuricemia (HU), hypercholesterolemia + hyperuricemia (HC + HU) and high-purine with 30-mg/kg/d losartan (HU + losartan) groups." | 7.81 | Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model. ( Ding, Y; Li, N; Miao, P; Zheng, H, 2015) |
| "Serum uric acid (SUA) levels correlate with many recognized cardiovascular risk factors, including age, male sex, hypertension, diabetes mellitus, hypertriglyceridemia, obesity, and insulin resistance." | 7.80 | Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. ( Borghi, C; Cicero, AF; D'Addato, S; Rosticci, M; Salvi, P, 2014) |
| "The aims of this study were to investigate (i) associations between uric acid and prevalent cardiovascular disease (CVD), ankle-arm blood pressure index (AAIx) and carotid intima-media thickness (CIMT) in the total population and in predefined subgroups according to glucose metabolism status and (ii) the extent to which these associations are explained by low-grade inflammation." | 7.80 | The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study. ( Arts, IC; Boonen, A; Dagnelie, PC; Ferreira, I; Feskens, EJ; Schalkwijk, CG; Stehouwer, CD; van der Kallen, CJ; van der Linden, S; van Greevenbroek, MM; Wijnands, JM, 2014) |
| "Uric acid and hsCRP levels are independently and positively associated with subclinical thoracic atherosclerosis." | 7.79 | Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis. ( Çaylı, M; Elbasan, Z; Gür, M; Kalkan, GY; Kaya, Z; Özaltun, B; Sahin, DY; Yıldız, A, 2013) |
| "Serum uric acid (SUA) is a potential risk factor for atherosclerosis." | 7.78 | Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. ( Bian, L; Choi, Y; Zhang, Z, 2012) |
| "Serum uric acid is a predictor of cardiac events and correlates to N-terminal pro-B-type natriuretic peptide and albuminuria, underscoring the importance of uric acid as a cardiovascular risk marker in patients with diabetes." | 7.78 | Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. ( Clodi, M; Hülsmann, M; Kromoser, H; Luger, A; Neuhold, S; Pacher, R; Prager, R; Resl, M; Riedl, M; Strunk, G; Vila, G, 2012) |
| "Serum uric acid (SUA) is a suggested biomarker for established coronary artery disease, but the role of SUA in early phases of atherosclerosis is controversial." | 7.78 | Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study. ( Hutri-Kähönen, N; Huupponen, R; Jula, A; Juonala, M; Kähönen, M; Lehtimäki, T; Loo, BM; Lyytikäinen, LP; Oikonen, M; Raitakari, OT; Saarikoski, L; Seppälä, I; Siitonen, N; Viikari, JS; Wendelin-Saarenhovi, M, 2012) |
| "In PsA patients without clinically evident CV disease there is a correlation between serum uric acid concentration and subclinical atherosclerosis." | 7.75 | Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. ( Gomez-Acebo, I; Gonzalez-Gay, MA; Gonzalez-Juanatey, C; Llorca, J; Martin, J; Miranda-Filloy, JA; Paz-Carreira, J; Vazquez-Rodriguez, TR, 2009) |
| " The aim of this study was to evaluate the relationships between serum uric acid concentration and degree of urinary albumin excretion as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus." | 7.74 | Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. ( Asano, M; Fukui, M; Harusato, I; Hasegawa, G; Hosoda, H; Kadono, M; Nakamura, N; Shiraishi, E; Tanaka, M; Yoshikawa, T, 2008) |
| "Serum uric acid has been positively associated with incident hypertension, but previous studies have had limited ability to explore this relationship across sex and ethnic strata." | 7.73 | Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. ( Bleyer, AJ; Erlinger, TP; Evans, GW; Herrington, DM; Mellen, PB; Nieto, FJ; Wagenknecht, LE; Wofford, MR, 2006) |
| "Hyperuricemia is associated with the activation of the Nod-like receptor protein 3 inflammasome." | 7.30 | C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study. ( Hayashi, T; Hiramitsu, S; Hisatome, I; Jinnouchi, H; Kakuda, H; Kawai, N; Kimura, K; Kojima, S; Matsui, K; Mori, H; Ogawa, H; Ohya, Y; Saito, Y; Sugawara, M; Tokutake, E; Tsujita, K; Uchiyama, K; Wakasa, Y; Waki, M; Yokota, N, 2023) |
| "Insulin resistance was assessed by the homeostatic model assessment (HOMA) index." | 5.56 | Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance. ( Andreozzi, F; Armentaro, G; Cassano, V; Crescibene, D; Hribal, ML; Magurno, M; Maio, R; Miceli, S; Pelaia, C; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Toscani, A, 2020) |
| "The cumulative incidence of vascular stenosis was significantly higher in subjects with hyperuricaemia than in those without hyperuricaemia (54." | 5.51 | Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis. ( Chen, J; Cheng, W; Cui, Q; Geng, B; Li, N; Song, M; Wang, K; Wang, Y; Yang, J; Yao, Y; Zhou, Y, 2019) |
| "Hyperuricemia is an independent predictor for early atherosclerosis in hypertensive subjects with normal renal function." | 5.38 | Uric acid is an important predictor for hypertensive early atherosclerosis. ( Bahadir, E; Citil, R; Deger, SM; Durmaz, AO; Mutluay, R; Sindel, S, 2012) |
| "Hyperuricaemia was associated with cardiac hypertrophy with an odds ratio (OR) of 1." | 5.36 | Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. ( Chen, CC; Chen, HW; Hung, KC; Hwang, JS; Ko, YS; Kuo, CF; Lin, CM; Lin, YS; Luo, SF; See, LC; Shen, YM; Tseng, WY; Wen, MS; Yu, KH, 2010) |
| "The European Lacidipine Study on Atherosclerosis (ELSA) was a randomized, double-blind, multicenter trial comparing the effects of a 4-year treatment with either lacidipine or atenolol on progression of carotid atherosclerosis in patients with moderate hypertension." | 5.30 | Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. ( Bombelli, M; Cuspidi, C; Facchetti, R; Grassi, G; Macchiarulo, M; Maggiolini, D; Mancia, G; Parati, G, 2019) |
| "Hyperuricemia is caused by reduced renal/extrarenal excretion and overproduction of uric acid." | 5.22 | Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease. ( Maeda, N; Nishizawa, H; Shimomura, I, 2022) |
| " A total of 500 patients with asymptomatic hyperuricemia (uric acid >7." | 5.22 | Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. ( Ako, J; Bando, YK; Eguchi, K; Higashi, Y; Inoue, T; Ishizaka, N; Ishizu, T; Kanzaki, Y; Kuroyanagi, T; Maemura, K; Murohara, T; Node, K; Ohishi, M; Oyama, J; Sata, M; Sato, Y; Taguchi, I; Tanaka, A; Teragawa, H; Tomiyama, H; Ueda, S; Yamada, H, 2016) |
| "The aim of this study was to investigate the long-term effective control of serum uric acid by allopurinol on the carotid intima-media thickness (IMT) in patients with type 2 diabetes (T2DM) and asymptomatic hyperuricemia (HUA)." | 5.20 | The Effects of Allopurinol on the Carotid Intima-media Thickness in Patients with Type 2 Diabetes and Asymptomatic Hyperuricemia: A Three-year Randomized Parallel-controlled Study. ( Chen, Y; Liu, P; Wang, D; Wang, H; Wang, Y; Zhang, F, 2015) |
| " Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases." | 5.12 | Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis. ( Kimura, Y; Kono, H; Tsukui, D, 2021) |
| "The role of uric acid (UA) in the process of atherothrombosis is controversial." | 5.12 | Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. ( Bandinelli, S; Cherubini, A; Ferrucci, L; Lauretani, F; Maggio, M; Miller, E; Najjar, SS; Ruggiero, C; Senin, U, 2007) |
| " Based on preclinical and clinical evidences, this review discusses: (i) stone forming risk factors, crystal nucleation, aggregation, injury-induced crystal retention, and stone formation, (ii) CVD risk factors such as dyslipidemia, perturbation of gut microbiome, obesity, free radical-induced lipoprotein oxidation, and retention in the arterial wall, subsequent foam cell formation, and atherosclerosis, (iii) mechanism by which stone forming risk factors such as oxalate, calcium, uric acid, and infection contribute toward CVDs, and (iv) how CVD risk factors, such as cholesterol, phospholipids, and uric acid, contribute to kidney stone formation are described." | 4.98 | Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases. ( Devarajan, A, 2018) |
| "The mechanisms of hyperhomocysteinemia (HHcy) and hyperuricemia (HUA) that promote atherosclerosis were seldom explored and always indefinite." | 4.95 | Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis. ( Chen, H; Chen, J; Gu, Y; Liu, N; Yang, K; Zhao, J, 2017) |
| "The relationship between elevated serum uric acid level and metabolic syndrome (MS) has been debated." | 4.90 | Association of serum uric acid and metabolic syndrome in type 2 diabetes. ( Bonakdaran, S; Kharaqani, B, 2014) |
| "Overall, the XO inhibitor febuxostat exerted protective effects against NASH and atherosclerosis in SHRSP5/Dmcr rats." | 4.31 | Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats. ( Fujii, M; Fukuoka, T; Hirohata, S; Honma, K; Kakimoto, M; Kirihara, S; Kitamori, K; Nakayama, H; Ran, S; Sato, I; Watanabe, S; Yamamoto, S, 2023) |
| " Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging." | 4.12 | Increased Impact of Serum Uric Acid on Arterial Stiffness and Atherosclerosis in Females. ( Dohi, Y; Iwase, M; Nagami, T; Ohte, N; Seo, Y; Sugiura, T; Suzuki, K; Takagi, Y; Takase, H; Tomiishi, T; Yokochi, T; Yoshikane, N, 2022) |
| "Uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) are positively and negatively associated with atherosclerosis, respectively." | 4.12 | Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis. ( Dong, H; Hu, X; Li, G; Li, W; Liu, J; Wang, C; Zhou, Y, 2022) |
| "The association between serum uric acid (UA) and atherosclerosis in old people is controversial." | 4.02 | Association between uric acid and atherosclerosis in community-dwelling older people: The SONIC study. ( Akagi, Y; Akasaka, H; Arai, Y; Godai, K; Gondo, Y; Ikebe, K; Ishizaki, T; Kabayama, M; Kamide, K; Kiyoshige, E; Masui, Y; Rakugi, H; Sekiguchi, T; Sugimoto, K; Takami, Y; Takeya, Y; Tanaka, K; Yamamoto, K; Yasumoto, S, 2021) |
| "We aimed to reveal the relationship of serum uric acid (SUA) with monocyte-high-density lipoprotein ratio (MHR) and other inflammatory markers in acne patients before and after isotretinoin treatment." | 4.02 | Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin. ( Metin, N; Turan, Ç, 2021) |
| "Uric acid is supposed but not yet determined to be associated with atherosclerosis." | 3.96 | Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation. ( Hosoyamada, M; Kimura, Y; Kono, H; Onda, A; Tsukui, D; Yanagida, T, 2020) |
| "Elevated serum uric acid (SUA) is associated with cardiovascular risk factors, which often contribute to dementia and dementia-like morbidity, yet several cross-sectional studies have shown protective associations with cognition, which would be consistent with other work showing benefits of elevated SUA through its antioxidant properties." | 3.96 | Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort. ( Alam, AB; Alonso, A; Power, MC; West, NA; Wu, A, 2020) |
| "This study investigated the association of serum uric acid (UA) with carotid fluoro-2-deoxyglucose (FDG) uptake as a marker of inflammatory atherosclerosis." | 3.96 | Serum uric acid in asymptomatic adults is weakly associated with carotid artery FDG uptake but not intima-media thickness. ( Bae, JH; Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Lee, KH; Moon, SH, 2020) |
| "The study aimed to determine the relationship among serum uric acid and metabolic syndrome and atherosclerosis, by means of carotid intima media-thickness, in a cohort of 811 otherwise healthy overweight/obese subjects, without overt atherosclerosis not using any kind of drug." | 3.88 | Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First? ( Caccavo, D; Carbonara, R; Ciccone, MM; Cortese, AM; Cortese, F; De Pergola, G; Masiello, M; Meliota, G; Silvestris, F; Termine, G, 2018) |
| "Allantoin is the main product of uric acid oxidation and was found to be augmented in atherosclerotic plaque in human autopsy and in animal models of atherosclerosis." | 3.88 | Allantoin as an independent marker associated with carotid intima-media thickness in subclinical atherosclerosis. ( Benseãor, IM; Lotufo, PA; Meotti, FC; Nascimento, KP; Santana, MS, 2018) |
| "This paper aims to evaluate the association between serum uric acid (SUA) levels, arterial hypertension (HT) prevalence, blood pressure values control, kidney function and intima media thickness (IMT), as a surrogate marker of early atherosclerosis, in a representative group of Romanian adult population." | 3.88 | Serum uric acid and arterial hypertension-Data from Sephar III survey. ( Buzas, R; Dorobantu, M; Ivan, V; Lighezan, D; Tautu, OF, 2018) |
| "Aim To determine the relationship of homocysteine (HCY), uric acid (UA) and C-reactive protein (CRP) in serum of patients with acute myocardial infarction (AMI) prior to application of percutaneous coronary intervention (PCI) and their level of correlation in serum of patients with normal and elevated CRP (predictor of worse cardiovascular outcomes)." | 3.88 | A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. ( Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M, 2018) |
| "Uric acid is a molecule that is known to act as a natural antioxidant in acute oxidative stress conditions such as acute ischemic stroke (AIS)." | 3.88 | Can high uric acid levels be an independent risk factor for acute ischemic stroke due to large-artery atherosclerosis? ( Acar, AB; Acar, T; Gül, SS; Güzey Aras, Y, 2018) |
| "We indicated that uric acid, AIP, and proteinuria are closely related." | 3.88 | Relationship Between Uric Acid, Proteinuria, and Atherogenic Index of Plasma in Renal Transplant Patients. ( Biyik, Z; Guney, I, 2018) |
| "Hyperuricemia and angiotensin II (Ang II) may have a pathogenetic role in the development of hypertension and atherosclerosis as well as cardiovascular disease (CVD) and its prognosis." | 3.85 | Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ. ( Çetin, A; Kırça, M; Oğuz, N; Uzuner, F; Yeşilkaya, A, 2017) |
| " Correlations between SA and atherosclerosis indicators, such as CIMT, LDL, hs-CRP, and uric acid, in hypothyroid individuals suggest that SA may be an indicator of atherogenesis in these patients." | 3.85 | Serum Total Sialic Acid Level is Elevated in Hypothyroid Patients as an Atherosclerotic Risk Factor. ( Aktürk, M; Altay, M; Arslan, M; Ateş, İ; Bukan, N; Çakır, N; Cerit, ET; Karakoç, MA; Yılmaz Demirtaş, C, 2017) |
| "Atherosclerosis induces the elevation of uric acid (UA), and an elevated UA level is well known to lead to a poor prognosis in patients with acute heart failure (AHF)." | 3.85 | Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia. ( Asai, K; Hata, N; Kobayashi, N; Matsushita, M; Nishigoori, S; Okazaki, H; Shibata, Y; Shibuya, J; Shimizu, W; Shinada, T; Shiomura, R; Shirakabe, A; Yamamoto, Y, 2017) |
| "We previously identified substantial laboratory drift in uric acid measurements in the Atherosclerosis Risk in Communities (ARIC) Study over time." | 3.83 | Iterative Outlier Removal: A Method for Identifying Outliers in Laboratory Recalibration Studies. ( Coresh, J; Couper, D; Eckfeldt, JH; Grams, ME; Li, D; Parrinello, CM; Sang, Y; Selvin, E; Wruck, LM, 2016) |
| " Whether gout, the most common rheumatologic inflammatory arthritis, or its cause, elevated serum uric acid (SUA), is associated with VTE incidence is unknown." | 3.83 | Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. ( Folsom, AR; Kubota, Y; McAdams-DeMarco, M, 2016) |
| "Serum uric acid (SUA) is associated with many cardiovascular risk factors such as hypertension (HTN) and metabolic syndrome (MetS)." | 3.81 | Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. ( Bao, YQ; Dong, XH; Jia, WP; Li, LX; Li, MF; Li, TT; Shen, J; Zhang, R, 2015) |
| "The aim of this study was to examine the association between uric acid (UA) level during pregnancy and future maternal hospitalization for atherosclerotic-related morbidity." | 3.81 | High Uric Acid Levels During Pregnancy Linked to Increased Risk for Future Atherosclerotic-Related Hospitalization. ( Sergienko, R; Sheiner, E; Shoham-Vardi, I; Wolak, T, 2015) |
| "The results show that mood disorders, TUD and BMI together with elevated levels of uric acid and MDA independently contribute to increased atherogenic potential, while BMI and uric acid are risk factors for insulin resistance." | 3.81 | Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder. ( Barbosa, DS; Berk, M; Bortolasci, CC; de Castro, MR; de Melo, LG; Dodd, S; Maes, M; Moreira, EG; Vargas Nunes, SO; Vargas, HO, 2015) |
| "Male rabbits (n = 48) were divided into control, hyperuricemia (HU), hypercholesterolemia + hyperuricemia (HC + HU) and high-purine with 30-mg/kg/d losartan (HU + losartan) groups." | 3.81 | Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model. ( Ding, Y; Li, N; Miao, P; Zheng, H, 2015) |
| "Serum uric acid (SUA) levels correlate with many recognized cardiovascular risk factors, including age, male sex, hypertension, diabetes mellitus, hypertriglyceridemia, obesity, and insulin resistance." | 3.80 | Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. ( Borghi, C; Cicero, AF; D'Addato, S; Rosticci, M; Salvi, P, 2014) |
| "In the univariate analysis, the major risk factors for kidney dysfunction in the patients with the cardio-cerebrovascular disease were age, gender, hypertension, diabetes mellitus, dyslipidemia and serum uric acid." | 3.80 | High prevalence and risk factors for kidney dysfunction in patients with atherosclerotic cardio-cerebrovascular disease. ( Bao, YS; Ji, Y; Jia, XB; Na, SP; Yang, J; Zhao, SL, 2014) |
| "Increased serum uric acid levels and vascular atherosclerosis are very common in diabetes." | 3.80 | Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus. ( Sun, H; Xiang, G; Xiang, L; Zhang, J, 2014) |
| "The aims of this study were to investigate (i) associations between uric acid and prevalent cardiovascular disease (CVD), ankle-arm blood pressure index (AAIx) and carotid intima-media thickness (CIMT) in the total population and in predefined subgroups according to glucose metabolism status and (ii) the extent to which these associations are explained by low-grade inflammation." | 3.80 | The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study. ( Arts, IC; Boonen, A; Dagnelie, PC; Ferreira, I; Feskens, EJ; Schalkwijk, CG; Stehouwer, CD; van der Kallen, CJ; van der Linden, S; van Greevenbroek, MM; Wijnands, JM, 2014) |
| "There was direct relationship between level of CV risk and presence of additional risk factors (hyperglycemia, hyperuricemia, hyperfibrinogenemia, left ventricular hypertrophy)." | 3.80 | [Detection of early markers of atherosclerosis in men with various levels of risk of cardiovascular complications]. ( Badeĭnikova, KK; Didigova, RT; Mamedov, MN; Mazaev, AP; Toguzova, ZA, 2014) |
| "The non-traditional risk factors for atherosclerotic lesions of the cardiovascular system (C-reactive protein, uric acid, fibrinogen, homocysteine) in blood plasma of patients with manifestative hypothyroidism at the age of 23 to 73 years were assessed in the study." | 3.79 | [Atypical risk factors of atherosclerosis in patients with hypothyroidism]. ( Mykhaĭlenko, OIu, 2013) |
| "Uric acid and hsCRP levels are independently and positively associated with subclinical thoracic atherosclerosis." | 3.79 | Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis. ( Çaylı, M; Elbasan, Z; Gür, M; Kalkan, GY; Kaya, Z; Özaltun, B; Sahin, DY; Yıldız, A, 2013) |
| "Serum uric acid (SUA) is a potential risk factor for atherosclerosis." | 3.78 | Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. ( Bian, L; Choi, Y; Zhang, Z, 2012) |
| "Serum uric acid is a predictor of cardiac events and correlates to N-terminal pro-B-type natriuretic peptide and albuminuria, underscoring the importance of uric acid as a cardiovascular risk marker in patients with diabetes." | 3.78 | Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. ( Clodi, M; Hülsmann, M; Kromoser, H; Luger, A; Neuhold, S; Pacher, R; Prager, R; Resl, M; Riedl, M; Strunk, G; Vila, G, 2012) |
| "We investigated the relationship among serum cardiac biomarkers including N-terminal pro-brain natriuretic peptide (NT-pro-BNP), cardiac troponin T (cTnT), uric acid and high-sensitive C-reactive protein (hs-CRP) and noninvasive predictors of atherosclerosis including carotid intima-media thickness (IMT), aortic stiffness (pulse wave velocity (PWV)) and transthoracic coronary flow reserve (CFR) in peritoneal dialysis (PD) patients." | 3.78 | Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients. ( Akagun, T; Alpay, N; Bozfakioglu, S; Caliskan, Y; Ecder, T; Guz, G; Ozkok, A; Polat, N; Tufan, F, 2012) |
| "Serum uric acid (SUA) is a suggested biomarker for established coronary artery disease, but the role of SUA in early phases of atherosclerosis is controversial." | 3.78 | Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study. ( Hutri-Kähönen, N; Huupponen, R; Jula, A; Juonala, M; Kähönen, M; Lehtimäki, T; Loo, BM; Lyytikäinen, LP; Oikonen, M; Raitakari, OT; Saarikoski, L; Seppälä, I; Siitonen, N; Viikari, JS; Wendelin-Saarenhovi, M, 2012) |
| "High serum uric acid levels are associated with gout, atherosclerosis and cardiovascular disease." | 3.76 | Sex and age interaction with genetic association of atherogenic uric acid concentrations. ( Adams, TD; Brandstätter, A; Coassin, S; Hunt, SC; Kedenko, L; Kiechl, S; Kramer, F; Kronenberg, F; Lamina, C; Paulweber, B; Summerer, M; Willeit, J, 2010) |
| "In PsA patients without clinically evident CV disease there is a correlation between serum uric acid concentration and subclinical atherosclerosis." | 3.75 | Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. ( Gomez-Acebo, I; Gonzalez-Gay, MA; Gonzalez-Juanatey, C; Llorca, J; Martin, J; Miranda-Filloy, JA; Paz-Carreira, J; Vazquez-Rodriguez, TR, 2009) |
| " The aim of this study was to evaluate the relationships between serum uric acid concentration and degree of urinary albumin excretion as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus." | 3.74 | Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. ( Asano, M; Fukui, M; Harusato, I; Hasegawa, G; Hosoda, H; Kadono, M; Nakamura, N; Shiraishi, E; Tanaka, M; Yoshikawa, T, 2008) |
| "The role of uric acid (UA) in the process of atherosclerosis and atherotrombosis is controversial." | 3.73 | Uric acid and inflammatory markers. ( Bandinelli, S; Ble, A; Bos, AJ; Cherubini, A; Dixit, VD; Ferrucci, L; Lauretani, F; Maggio, M; Ruggiero, C; Senin, U, 2006) |
| "Serum uric acid has been positively associated with incident hypertension, but previous studies have had limited ability to explore this relationship across sex and ethnic strata." | 3.73 | Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. ( Bleyer, AJ; Erlinger, TP; Evans, GW; Herrington, DM; Mellen, PB; Nieto, FJ; Wagenknecht, LE; Wofford, MR, 2006) |
| "Hyperuricemia is associated with the activation of the Nod-like receptor protein 3 inflammasome." | 3.30 | C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study. ( Hayashi, T; Hiramitsu, S; Hisatome, I; Jinnouchi, H; Kakuda, H; Kawai, N; Kimura, K; Kojima, S; Matsui, K; Mori, H; Ogawa, H; Ohya, Y; Saito, Y; Sugawara, M; Tokutake, E; Tsujita, K; Uchiyama, K; Wakasa, Y; Waki, M; Yokota, N, 2023) |
| "Although hyperuricemia is undoubtedly related to CKD, controversial findings have been hitherto reported in patients treated with urate-lowering therapies." | 2.82 | Chronic kidney disease: Which role for xanthine oxidoreductase activity and products? ( Battelli, MG; Bolognesi, A; Bortolotti, M; Polito, L, 2022) |
| "Atherosclerosis is regarded as the disease of the arterial vasculature." | 2.72 | Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. ( Jayachandran, M; Qu, S, 2021) |
| " In the process of purine metabolism, reactive oxygen species, including superoxide, are generated concomitantly with uric acid production, which may deteriorate endothelial function through the reaction of superoxide with nitric oxide (NO), leading to decreased NO bioavailability and increased production of peroxynitrite, a reactive oxidant." | 2.58 | Hyperuricemia and endothelial function: From molecular background to clinical perspectives. ( Higashi, Y; Hisatome, I; Kihara, Y; Maruhashi, T, 2018) |
| "Hypertension is an established risk factor of cardiovascular morbidity and mortality." | 2.52 | [The First Step Aiming at the Prevention of Hypertension and Atherosclerosis. Identification of Individuals at High Risk of Hypertension]. ( Dohi, Y, 2015) |
| "Uric acid has been formerly considered a major antioxidant in human plasma with possible beneficial anti-atherosclerotic effects." | 2.48 | Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. ( Cravero, E; Muscari, A; Puddu, GM; Puddu, P; Vizioli, L, 2012) |
| "Acute rupture or erosion of unstable atherosclerotic plaques is a major cause of adverse consequences of atherosclerotic cardiovascular disease, often leading to myocardial infarction or stroke." | 1.91 | High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy. ( Chen, B; Cheng, J; He, F; Koyama, H; Liu, W; Lv, J; Wang, Q; Xu, C; Yamamoto, T; Yu, W; Zhao, H, 2023) |
| "In conclusion, Hyperuricemia is prevalent among Chinese adults." | 1.72 | Association of Hyperuricemia with 10-Year Atherosclerotic Cardiovascular Disease Risk among Chinese Adults and Elders. ( Chen, F; Han, S; Liu, J; Xu, T; Yuan, L, 2022) |
| "Uric acid is an effective antioxidant." | 1.62 | Protective Effect of Uric Acid on ox-LDL-Induced HUVECs Injury via Keap1-Nrf2-ARE Pathway. ( Bi, H; Hao, Z; Lin, Y; Liu, Y; Xia, Y; Xie, Y; Yang, X, 2021) |
| "Hyperuricemia was often found in subjects with an elevated risk of cardiovascular disease (CVD)." | 1.56 | Clinical relevance of serum uric acid and abdominal aortic-calcification in a national survey. ( Chen, WL; Li, YW, 2020) |
| "Insulin resistance was assessed by the homeostatic model assessment (HOMA) index." | 1.56 | Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance. ( Andreozzi, F; Armentaro, G; Cassano, V; Crescibene, D; Hribal, ML; Magurno, M; Maio, R; Miceli, S; Pelaia, C; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Toscani, A, 2020) |
| "We enrolled 37 ADPKD patients (20 males with 51." | 1.51 | Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease. ( Cianci, R; Ciccariello, M; Lai, S; Mastroluca, D; Mazzaferro, S; Mittherhofer, AP; Ricciuti, GP; Riviello, L; Salciccia, S; Vocaturi, M; Von Heland, M, 2019) |
| "The cumulative incidence of vascular stenosis was significantly higher in subjects with hyperuricaemia than in those without hyperuricaemia (54." | 1.51 | Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis. ( Chen, J; Cheng, W; Cui, Q; Geng, B; Li, N; Song, M; Wang, K; Wang, Y; Yang, J; Yao, Y; Zhou, Y, 2019) |
| "Experimental diabetes mellitus was produced by a single intraperitoneal injection of STZ (55mg/kg b." | 1.43 | Antihyperglycemic and antidiabetic effects of Ethyl (S)-2-(1-cyclohexylsulfamide carbamoyloxy) propanoate in streptozotocin-induced diabetic Wistar rats. ( Berredjem, H; Berredjem, M; Bouzerna, N; Cheloufi, H; Réggami, Y, 2016) |
| "Epilepsy is a chronic disease that affects metabolism either alone or through the antiepileptic drug (AED) treatment." | 1.42 | Epilepsy and antiepileptic drugs: risk factors for atherosclerosis. ( Abdelaziz, GH; Ahmed, SM; El-Jaafary, SI; Kamel, T; Rabah, AM; Talaat, FM, 2015) |
| "Hyperuricemia is an important risk factor for atherosclerosis, yet the potential mechanisms are not well understood." | 1.42 | Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling. ( Feng, XR; Liang, WY; Liu, ML; Wang, YC; Zhang, JW; Zhu, XY, 2015) |
| "Atherosclerosis is considered as an inflammatory disease, and carotid artery intima-media thickness (IMT) and carotid plaque are generally used as intermediated phenotype of atherosclerosis." | 1.42 | Association of interleukin-10 promoter region polymorphisms with risk factors of Atherosclerosis. ( Cho, HC; Chung, IS; Chung, JH; Jun, SE; Park, KO; Shin, DH; Yu, GI, 2015) |
| "Hyperuricemia is an independent predictor for early atherosclerosis in hypertensive subjects with normal renal function." | 1.38 | Uric acid is an important predictor for hypertensive early atherosclerosis. ( Bahadir, E; Citil, R; Deger, SM; Durmaz, AO; Mutluay, R; Sindel, S, 2012) |
| "Atherosclerotic plaque formation and vascular calcinosis were modeled in a subchronic experiment." | 1.38 | Biochemical indicators of atherogenic and protective activity of xydiphone in experimental animals. ( Dreval, AA; Ilyushina, IA; Murashov, AN; Pimenov, MS; Sukhorukov, VS; Yur'eva, EA, 2012) |
| "Hyperuricaemia was associated with cardiac hypertrophy with an odds ratio (OR) of 1." | 1.36 | Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. ( Chen, CC; Chen, HW; Hung, KC; Hwang, JS; Ko, YS; Kuo, CF; Lin, CM; Lin, YS; Luo, SF; See, LC; Shen, YM; Tseng, WY; Wen, MS; Yu, KH, 2010) |
| "Hyperuricemia is postulated to be a risk factor for atherosclerotic diseases, although whether it is independent of classical atherogenic risk factors is controversial." | 1.34 | Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. ( Hashimoto, H; Ishizaka, N; Ishizaka, Y; Nagai, R; Toda, E; Yamakado, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (2.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 24 (16.90) | 29.6817 |
| 2010's | 85 (59.86) | 24.3611 |
| 2020's | 29 (20.42) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Y | 1 |
| Qu, Y | 1 |
| Lv, X | 1 |
| Zhao, R | 1 |
| Yu, J | 1 |
| Hu, S | 1 |
| Kang, J | 1 |
| Zhang, Y | 1 |
| Gong, Y | 1 |
| Cui, T | 1 |
| Zhang, X | 1 |
| Yan, Y | 2 |
| Teng, MS | 1 |
| Wu, S | 1 |
| Hsu, LA | 1 |
| Chou, HH | 1 |
| Ko, YL | 1 |
| Lin, Y | 1 |
| Xie, Y | 1 |
| Hao, Z | 1 |
| Bi, H | 1 |
| Liu, Y | 1 |
| Yang, X | 1 |
| Xia, Y | 1 |
| Kimura, Y | 2 |
| Tsukui, D | 2 |
| Kono, H | 2 |
| Nishizawa, H | 1 |
| Maeda, N | 1 |
| Shimomura, I | 1 |
| Sugiura, T | 1 |
| Dohi, Y | 2 |
| Takagi, Y | 1 |
| Yokochi, T | 1 |
| Yoshikane, N | 1 |
| Suzuki, K | 1 |
| Tomiishi, T | 1 |
| Nagami, T | 1 |
| Iwase, M | 1 |
| Takase, H | 1 |
| Ohte, N | 1 |
| Seo, Y | 1 |
| Shiina, K | 1 |
| Tomiyama, H | 2 |
| Tanaka, A | 2 |
| Yoshida, H | 1 |
| Eguchi, K | 2 |
| Kario, K | 1 |
| Kato, T | 1 |
| Teragawa, H | 2 |
| Toyoda, S | 1 |
| Ohishi, M | 2 |
| Fukumoto, Y | 1 |
| Takase, B | 1 |
| Ishizu, T | 2 |
| Node, K | 2 |
| Ma, M | 1 |
| Wang, L | 2 |
| Zhong, X | 1 |
| Zhong, L | 1 |
| Chen, R | 1 |
| Li, L | 1 |
| Mao, M | 1 |
| Hu, X | 1 |
| Liu, J | 2 |
| Li, W | 1 |
| Wang, C | 2 |
| Li, G | 1 |
| Zhou, Y | 3 |
| Dong, H | 1 |
| Yu, W | 4 |
| Liu, W | 4 |
| Wang, Q | 4 |
| Xu, C | 4 |
| Zhao, H | 4 |
| Lv, J | 4 |
| He, F | 4 |
| Chen, B | 4 |
| Yamamoto, T | 4 |
| Koyama, H | 4 |
| Cheng, J | 4 |
| Baessler, A | 1 |
| Fischer, M | 1 |
| Kojima, S | 1 |
| Uchiyama, K | 1 |
| Yokota, N | 1 |
| Tokutake, E | 1 |
| Wakasa, Y | 1 |
| Hiramitsu, S | 1 |
| Waki, M | 1 |
| Jinnouchi, H | 1 |
| Kakuda, H | 1 |
| Hayashi, T | 1 |
| Kawai, N | 1 |
| Sugawara, M | 1 |
| Mori, H | 1 |
| Tsujita, K | 1 |
| Matsui, K | 1 |
| Hisatome, I | 2 |
| Ohya, Y | 1 |
| Kimura, K | 1 |
| Saito, Y | 1 |
| Ogawa, H | 1 |
| Chen, F | 1 |
| Yuan, L | 1 |
| Xu, T | 1 |
| Han, S | 1 |
| Polito, L | 2 |
| Bortolotti, M | 1 |
| Battelli, MG | 2 |
| Bolognesi, A | 2 |
| Mello, FM | 3 |
| Bensenor, IM | 3 |
| Santos, IS | 3 |
| Bittencourt, MS | 3 |
| Lotufo, PA | 4 |
| Fuller, R | 3 |
| Şaylık, F | 1 |
| Çınar, T | 1 |
| Selçuk, M | 1 |
| Tanboğa, İH | 1 |
| Kakimoto, M | 1 |
| Fujii, M | 1 |
| Sato, I | 1 |
| Honma, K | 1 |
| Nakayama, H | 1 |
| Kirihara, S | 1 |
| Fukuoka, T | 1 |
| Ran, S | 1 |
| Hirohata, S | 1 |
| Kitamori, K | 1 |
| Yamamoto, S | 1 |
| Watanabe, S | 1 |
| He, B | 1 |
| Nie, Q | 1 |
| Wang, F | 1 |
| Wang, X | 1 |
| Guo, J | 1 |
| Fan, X | 1 |
| Ye, Z | 1 |
| Liu, P | 2 |
| Wen, J | 1 |
| Mazidi, M | 2 |
| Katsiki, N | 2 |
| Mikhailidis, DP | 2 |
| Bartłomiejczyk, MA | 1 |
| Banach, M | 2 |
| Yuan, Y | 1 |
| Hu, JW | 1 |
| Wang, Y | 3 |
| Wang, KK | 1 |
| Zheng, WL | 1 |
| Chu, C | 1 |
| Ma, Q | 1 |
| Liao, YY | 1 |
| Mu, JJ | 1 |
| Yanagida, T | 1 |
| Onda, A | 1 |
| Hosoyamada, M | 1 |
| Luo, F | 1 |
| Zhuo, C | 1 |
| Alam, AB | 1 |
| Wu, A | 1 |
| Power, MC | 1 |
| West, NA | 1 |
| Alonso, A | 2 |
| Li, YW | 1 |
| Chen, WL | 1 |
| Cassano, V | 1 |
| Crescibene, D | 1 |
| Hribal, ML | 1 |
| Pelaia, C | 1 |
| Armentaro, G | 1 |
| Magurno, M | 1 |
| Toscani, A | 1 |
| Miceli, S | 1 |
| Andreozzi, F | 1 |
| Maio, R | 1 |
| Perticone, M | 1 |
| Sesti, G | 1 |
| Perticone, F | 1 |
| Sciacqua, A | 1 |
| Jayachandran, M | 1 |
| Qu, S | 1 |
| Tanaka, K | 1 |
| Kabayama, M | 1 |
| Sugimoto, K | 1 |
| Akasaka, H | 1 |
| Takami, Y | 1 |
| Takeya, Y | 1 |
| Yamamoto, K | 1 |
| Sekiguchi, T | 1 |
| Kiyoshige, E | 1 |
| Akagi, Y | 1 |
| Godai, K | 1 |
| Yasumoto, S | 1 |
| Masui, Y | 1 |
| Gondo, Y | 1 |
| Ikebe, K | 1 |
| Arai, Y | 1 |
| Ishizaki, T | 1 |
| Rakugi, H | 1 |
| Kamide, K | 1 |
| Metin, N | 1 |
| Turan, Ç | 1 |
| Nansseu, JR | 2 |
| Ama Moor, VJ | 1 |
| Takam, RDM | 1 |
| Zing-Awona, B | 2 |
| Azabji-Kenfack, M | 1 |
| Tankeu, F | 1 |
| Tchoula, CM | 1 |
| Moukette, BM | 1 |
| Ngogang, JY | 1 |
| Hannawi, S | 1 |
| AlSalmi, I | 1 |
| Moller, I | 1 |
| Naredo, E | 1 |
| Zhao, J | 2 |
| Chen, H | 2 |
| Liu, N | 1 |
| Chen, J | 3 |
| Gu, Y | 1 |
| Yang, K | 1 |
| Shen, S | 1 |
| Qi, H | 1 |
| He, X | 1 |
| Lu, Y | 1 |
| Yang, C | 1 |
| Li, F | 1 |
| Qiang, D | 1 |
| Shui, K | 1 |
| Zhou, L | 1 |
| Weng, X | 1 |
| Shen, Z | 1 |
| Wu, L | 1 |
| De Pergola, G | 1 |
| Cortese, F | 1 |
| Termine, G | 1 |
| Meliota, G | 1 |
| Carbonara, R | 1 |
| Masiello, M | 1 |
| Cortese, AM | 1 |
| Silvestris, F | 1 |
| Caccavo, D | 1 |
| Ciccone, MM | 1 |
| Devarajan, A | 1 |
| Santana, MS | 1 |
| Nascimento, KP | 1 |
| Benseãor, IM | 1 |
| Meotti, FC | 1 |
| Buzas, R | 1 |
| Tautu, OF | 1 |
| Dorobantu, M | 1 |
| Ivan, V | 1 |
| Lighezan, D | 1 |
| Marković Boras, M | 1 |
| Čaušević, A | 1 |
| Brizić, I | 1 |
| Mikulić, I | 1 |
| Vasilj, M | 1 |
| Jelić Knezović, N | 1 |
| Acar, T | 1 |
| Güzey Aras, Y | 1 |
| Gül, SS | 1 |
| Acar, AB | 1 |
| Cho, YS | 1 |
| Bae, JH | 1 |
| Moon, SH | 1 |
| Hyun, SH | 1 |
| Choi, JY | 1 |
| Kim, BT | 1 |
| Lee, KH | 1 |
| Maruhashi, T | 1 |
| Kihara, Y | 1 |
| Higashi, Y | 2 |
| Biyik, Z | 1 |
| Guney, I | 1 |
| Bombelli, M | 1 |
| Macchiarulo, M | 1 |
| Facchetti, R | 1 |
| Maggiolini, D | 1 |
| Cuspidi, C | 1 |
| Parati, G | 1 |
| Mancia, G | 1 |
| Grassi, G | 1 |
| Antonini-Canterin, F | 1 |
| Di Nora, C | 1 |
| Pellegrinet, M | 1 |
| Vriz, O | 1 |
| La Carrubba, S | 1 |
| Carerj, S | 1 |
| Zito, C | 1 |
| Matescu, A | 1 |
| Ravasel, A | 1 |
| Cosei, I | 1 |
| Popescu, BA | 1 |
| Lai, S | 1 |
| Mittherhofer, AP | 1 |
| Cianci, R | 1 |
| Riviello, L | 1 |
| Vocaturi, M | 1 |
| Mastroluca, D | 1 |
| Ciccariello, M | 1 |
| Von Heland, M | 1 |
| Ricciuti, GP | 1 |
| Salciccia, S | 1 |
| Mazzaferro, S | 1 |
| Concistrè, A | 1 |
| Petramala, L | 1 |
| Bisogni, V | 1 |
| Mezzadri, M | 1 |
| Olmati, F | 1 |
| Saracino, V | 1 |
| Oliviero, G | 1 |
| Bonvicini, M | 1 |
| Tonnarini, G | 1 |
| Iannucci, G | 1 |
| Letizia, C | 1 |
| Song, M | 1 |
| Li, N | 2 |
| Yao, Y | 1 |
| Wang, K | 1 |
| Yang, J | 2 |
| Cui, Q | 1 |
| Geng, B | 1 |
| Cheng, W | 1 |
| Wang, A | 1 |
| Barber, JR | 1 |
| Tin, A | 1 |
| De Marzo, AM | 1 |
| Kottgen, A | 3 |
| Joshu, CE | 1 |
| Platz, EA | 1 |
| Kupusinac, A | 1 |
| Doroslovački, R | 1 |
| Malbaški, D | 1 |
| Srdić, B | 1 |
| Stokić, E | 1 |
| Wang, H | 2 |
| Jacobs, DR | 1 |
| Gaffo, AL | 1 |
| Gross, MD | 1 |
| Goff, DC | 1 |
| Carr, JJ | 1 |
| Cicero, AF | 1 |
| Salvi, P | 1 |
| D'Addato, S | 1 |
| Rosticci, M | 1 |
| Borghi, C | 1 |
| Bao, YS | 1 |
| Jia, XB | 1 |
| Ji, Y | 1 |
| Zhao, SL | 1 |
| Na, SP | 1 |
| Knowles, JW | 1 |
| Reaven, G | 1 |
| Bonakdaran, S | 1 |
| Kharaqani, B | 1 |
| Zhang, J | 1 |
| Xiang, G | 1 |
| Xiang, L | 1 |
| Sun, H | 1 |
| Sarmento, PL | 1 |
| Plavnik, FL | 1 |
| Scaciota, A | 1 |
| Lima, JO | 1 |
| Miranda, RB | 1 |
| Ajzen, SA | 1 |
| Roszkowska, R | 1 |
| Taranta-Janusz, K | 1 |
| Tenderenda-Banasiuk, E | 1 |
| Wasilewska, A | 1 |
| Wijnands, JM | 1 |
| Boonen, A | 1 |
| Dagnelie, PC | 1 |
| van Greevenbroek, MM | 1 |
| van der Kallen, CJ | 1 |
| Ferreira, I | 1 |
| Schalkwijk, CG | 1 |
| Feskens, EJ | 1 |
| Stehouwer, CD | 1 |
| van der Linden, S | 1 |
| Arts, IC | 1 |
| Talaat, FM | 1 |
| Kamel, T | 1 |
| Rabah, AM | 1 |
| Ahmed, SM | 1 |
| El-Jaafary, SI | 1 |
| Abdelaziz, GH | 1 |
| Badeĭnikova, KK | 1 |
| Mazaev, AP | 1 |
| Toguzova, ZA | 1 |
| Mamedov, MN | 1 |
| Didigova, RT | 1 |
| Solomenchuk, TN | 1 |
| Semegen-Bodak, KV | 1 |
| Slaba, NA | 1 |
| Chngrian, GV | 1 |
| Mysyshin, MB | 1 |
| Rasheed, H | 1 |
| Hughes, K | 1 |
| Flynn, TJ | 1 |
| Merriman, TR | 1 |
| Kosacka, M | 1 |
| Brzecka, A | 1 |
| Piesiak, P | 1 |
| Korzeniewska, A | 1 |
| Jankowska, R | 1 |
| Liang, WY | 1 |
| Zhu, XY | 1 |
| Zhang, JW | 1 |
| Feng, XR | 1 |
| Wang, YC | 1 |
| Liu, ML | 1 |
| Li, LX | 1 |
| Dong, XH | 1 |
| Li, MF | 1 |
| Zhang, R | 1 |
| Li, TT | 1 |
| Shen, J | 2 |
| Bao, YQ | 1 |
| Jia, WP | 1 |
| Yu, GI | 1 |
| Jun, SE | 1 |
| Cho, HC | 1 |
| Park, KO | 1 |
| Chung, JH | 1 |
| Shin, DH | 1 |
| Chung, IS | 1 |
| Mayer, FJ | 1 |
| Mannhalter, C | 1 |
| Minar, E | 1 |
| Schillinger, M | 1 |
| Chavakis, T | 1 |
| Siegert, G | 1 |
| Arneth, BM | 1 |
| Koppensteiner, R | 1 |
| Hoke, M | 1 |
| Mykhaĭlenko, OIu | 1 |
| Chen, Y | 4 |
| Xu, B | 1 |
| Sun, W | 1 |
| Sun, J | 1 |
| Wang, T | 1 |
| Xu, Y | 1 |
| Xu, M | 2 |
| Lu, J | 1 |
| Li, X | 1 |
| Bi, Y | 1 |
| Wang, W | 2 |
| Ning, G | 1 |
| Wolak, T | 1 |
| Shoham-Vardi, I | 1 |
| Sergienko, R | 1 |
| Sheiner, E | 1 |
| Bortolasci, CC | 1 |
| Vargas, HO | 1 |
| Vargas Nunes, SO | 1 |
| de Melo, LG | 1 |
| de Castro, MR | 1 |
| Moreira, EG | 1 |
| Dodd, S | 1 |
| Barbosa, DS | 1 |
| Berk, M | 1 |
| Maes, M | 2 |
| Altun, B | 1 |
| Cintosun, U | 1 |
| Ozturk, K | 1 |
| Zhang, F | 1 |
| Wang, D | 1 |
| Kummer, AE | 1 |
| Grams, M | 2 |
| Lutsey, P | 1 |
| Matsushita, K | 1 |
| Folsom, AR | 2 |
| Coresh, J | 3 |
| Castejon, R | 1 |
| Jimenez-Ortiz, C | 1 |
| Rosado, S | 1 |
| Tutor-Ureta, P | 1 |
| Mellor-Pita, S | 1 |
| Yebra-Bango, M | 1 |
| Zheng, H | 1 |
| Ding, Y | 1 |
| Miao, P | 1 |
| Burke, BT | 1 |
| Law, A | 1 |
| Baer, AN | 1 |
| McAdams-DeMarco, MA | 1 |
| Moor, VJ | 1 |
| Nouaga, ME | 1 |
| Tchanana, G | 1 |
| Ketcha, A | 1 |
| Réggami, Y | 1 |
| Berredjem, H | 1 |
| Cheloufi, H | 1 |
| Berredjem, M | 1 |
| Bouzerna, N | 1 |
| Parrinello, CM | 1 |
| Grams, ME | 1 |
| Sang, Y | 1 |
| Couper, D | 1 |
| Wruck, LM | 1 |
| Li, D | 1 |
| Eckfeldt, JH | 1 |
| Selvin, E | 1 |
| Oyama, J | 1 |
| Sato, Y | 1 |
| Sata, M | 1 |
| Taguchi, I | 1 |
| Kuroyanagi, T | 1 |
| Ishizaka, N | 2 |
| Kanzaki, Y | 1 |
| Yamada, H | 1 |
| Maemura, K | 1 |
| Ako, J | 1 |
| Bando, YK | 1 |
| Ueda, S | 1 |
| Inoue, T | 1 |
| Murohara, T | 1 |
| Kubota, Y | 1 |
| McAdams-DeMarco, M | 1 |
| Kırça, M | 1 |
| Oğuz, N | 1 |
| Çetin, A | 1 |
| Uzuner, F | 1 |
| Yeşilkaya, A | 1 |
| Altay, M | 1 |
| Karakoç, MA | 1 |
| Çakır, N | 1 |
| Yılmaz Demirtaş, C | 1 |
| Cerit, ET | 1 |
| Aktürk, M | 1 |
| Ateş, İ | 1 |
| Bukan, N | 1 |
| Arslan, M | 1 |
| Chang, Y | 1 |
| Li, Y | 2 |
| Guo, X | 1 |
| Guo, L | 1 |
| Sun, Y | 1 |
| Okazaki, H | 1 |
| Shirakabe, A | 1 |
| Kobayashi, N | 1 |
| Hata, N | 1 |
| Shinada, T | 1 |
| Matsushita, M | 1 |
| Yamamoto, Y | 1 |
| Shibata, Y | 1 |
| Shibuya, J | 1 |
| Shiomura, R | 1 |
| Nishigoori, S | 1 |
| Asai, K | 1 |
| Shimizu, W | 1 |
| Kushiyama, A | 1 |
| Nakatsu, Y | 1 |
| Matsunaga, Y | 1 |
| Yamamotoya, T | 1 |
| Mori, K | 1 |
| Ueda, K | 1 |
| Inoue, Y | 1 |
| Sakoda, H | 1 |
| Fujishiro, M | 1 |
| Ono, H | 1 |
| Asano, T | 1 |
| Oliveira, SR | 1 |
| Kallaur, AP | 1 |
| Lopes, J | 1 |
| Colado Simão, AN | 1 |
| Reiche, EM | 1 |
| de Almeida, ERD | 1 |
| Morimoto, HK | 1 |
| de Carvalho Jennings de Pereira, WL | 1 |
| Alfieri, DF | 1 |
| Flauzino, T | 1 |
| de Meleck Proença, C | 1 |
| Gomes, AM | 1 |
| Kaimen-Maciel, DR | 1 |
| Qin, G | 1 |
| Chen, Z | 1 |
| Su, W | 1 |
| Geng, X | 1 |
| Chen, X | 1 |
| Xu, X | 1 |
| Pan, W | 1 |
| Auclair, S | 1 |
| Silberberg, M | 1 |
| Gueux, E | 1 |
| Morand, C | 1 |
| Mazur, A | 1 |
| Milenkovic, D | 1 |
| Scalbert, A | 1 |
| Vekic, J | 1 |
| Jelic-Ivanovic, Z | 1 |
| Spasojevic-Kalimanovska, V | 1 |
| Memon, L | 1 |
| Zeljkovic, A | 1 |
| Bogavac-Stanojevic, N | 1 |
| Spasic, S | 1 |
| Gonzalez-Gay, MA | 2 |
| Gonzalez-Juanatey, C | 2 |
| Vazquez-Rodriguez, TR | 2 |
| Gomez-Acebo, I | 1 |
| Miranda-Filloy, JA | 1 |
| Paz-Carreira, J | 1 |
| Martin, J | 1 |
| Llorca, J | 2 |
| Percario, S | 1 |
| Odorizzi, VF | 1 |
| Souza, DR | 1 |
| Pinhel, MA | 1 |
| Gennari, JL | 1 |
| Gennari, MS | 1 |
| Godoy, MF | 1 |
| Mosley, TH | 1 |
| Huang, X | 1 |
| Dierssen, T | 1 |
| Brandstätter, A | 1 |
| Lamina, C | 1 |
| Kiechl, S | 1 |
| Hunt, SC | 1 |
| Coassin, S | 1 |
| Paulweber, B | 1 |
| Kramer, F | 1 |
| Summerer, M | 1 |
| Willeit, J | 1 |
| Kedenko, L | 1 |
| Adams, TD | 1 |
| Kronenberg, F | 1 |
| Sabio, JM | 1 |
| Vargas-Hitos, JA | 1 |
| Mediavilla, JD | 1 |
| Navarrete-Navarrete, N | 1 |
| Zamora-Posadas, M | 1 |
| Pérez-Vicente, S | 1 |
| Hidalgo-Tenorio, C | 1 |
| Díaz-Chamorro, A | 1 |
| Jáimez, L | 1 |
| Jiménez-Alonso, J | 1 |
| Krishnan, E | 1 |
| Kuo, CF | 1 |
| Yu, KH | 1 |
| Luo, SF | 1 |
| Ko, YS | 1 |
| Wen, MS | 1 |
| Lin, YS | 1 |
| Hung, KC | 1 |
| Chen, CC | 1 |
| Lin, CM | 1 |
| Hwang, JS | 1 |
| Tseng, WY | 1 |
| Chen, HW | 1 |
| Shen, YM | 1 |
| See, LC | 1 |
| Kiseljaković, E | 1 |
| Valjevac, A | 1 |
| Hasić, S | 1 |
| Nakas-Ićindić, E | 1 |
| Dzubur, A | 1 |
| Jadrić, R | 1 |
| Gilardini, L | 1 |
| Pasqualinotto, L | 1 |
| Di Matteo, S | 1 |
| Caffetto, K | 1 |
| Croci, M | 1 |
| Girola, A | 1 |
| Invitti, C | 1 |
| Saeed, A | 1 |
| Herlitz, H | 1 |
| Nowakowska-Fortuna, E | 1 |
| Nilsson, U | 1 |
| Alhadad, A | 1 |
| Jensen, G | 1 |
| Mattiasson, I | 1 |
| Lindblad, B | 1 |
| Gottsäter, A | 1 |
| Guron, G | 1 |
| McIntyre, NJ | 1 |
| Fluck, RJ | 1 |
| McIntyre, CW | 1 |
| Taal, MW | 1 |
| Zhang, Z | 1 |
| Bian, L | 1 |
| Choi, Y | 1 |
| Resl, M | 1 |
| Clodi, M | 1 |
| Neuhold, S | 1 |
| Kromoser, H | 1 |
| Riedl, M | 1 |
| Vila, G | 1 |
| Prager, R | 1 |
| Pacher, R | 1 |
| Strunk, G | 1 |
| Luger, A | 1 |
| Hülsmann, M | 1 |
| Chuang, YC | 1 |
| Chuang, HY | 1 |
| Lin, TK | 1 |
| Chang, CC | 1 |
| Lu, CH | 1 |
| Chang, WN | 1 |
| Chen, SD | 1 |
| Tan, TY | 1 |
| Huang, CR | 1 |
| Chan, SH | 1 |
| Mutluay, R | 1 |
| Deger, SM | 1 |
| Bahadir, E | 1 |
| Durmaz, AO | 1 |
| Citil, R | 1 |
| Sindel, S | 1 |
| Puddu, P | 1 |
| Puddu, GM | 1 |
| Cravero, E | 1 |
| Vizioli, L | 1 |
| Muscari, A | 1 |
| Caliskan, Y | 1 |
| Ozkok, A | 1 |
| Akagun, T | 1 |
| Alpay, N | 1 |
| Guz, G | 1 |
| Polat, N | 1 |
| Tufan, F | 1 |
| Ecder, T | 1 |
| Bozfakioglu, S | 1 |
| D'Marco, L | 1 |
| García, I | 1 |
| Vega, C | 1 |
| Kushnarenko, NN | 1 |
| Govorin, AV | 1 |
| Shcherbakova, OA | 1 |
| Sotnikova, SG | 1 |
| Ivanitskaia, OV | 1 |
| Oikonen, M | 1 |
| Wendelin-Saarenhovi, M | 1 |
| Lyytikäinen, LP | 1 |
| Siitonen, N | 1 |
| Loo, BM | 1 |
| Jula, A | 1 |
| Seppälä, I | 1 |
| Saarikoski, L | 1 |
| Lehtimäki, T | 1 |
| Hutri-Kähönen, N | 1 |
| Juonala, M | 1 |
| Kähönen, M | 1 |
| Huupponen, R | 1 |
| Viikari, JS | 1 |
| Raitakari, OT | 1 |
| Yur'eva, EA | 1 |
| Sukhorukov, VS | 1 |
| Murashov, AN | 1 |
| Pimenov, MS | 1 |
| Ilyushina, IA | 1 |
| Dreval, AA | 1 |
| Baliarsingh, S | 1 |
| Sharma, N | 1 |
| Mukherjee, R | 1 |
| Gür, M | 1 |
| Sahin, DY | 1 |
| Elbasan, Z | 1 |
| Kalkan, GY | 1 |
| Yıldız, A | 1 |
| Kaya, Z | 1 |
| Özaltun, B | 1 |
| Çaylı, M | 1 |
| Liang, J | 1 |
| Zhou, N | 1 |
| Teng, F | 1 |
| Zou, C | 1 |
| Qi, L | 1 |
| PUIG-MUSET, P | 1 |
| LAPORTE, J | 1 |
| VALDECASAS, FG | 1 |
| HANSEN, OE | 1 |
| BARNETT, AJ | 1 |
| CARSON, V | 1 |
| DE MEIRING, PV | 1 |
| BEAUMONT, JL | 1 |
| SCHWARTZ, D | 1 |
| Saijo, Y | 1 |
| Utsugi, M | 1 |
| Yoshioka, E | 1 |
| Horikawa, N | 1 |
| Sato, T | 1 |
| Gong, YY | 1 |
| Kishi, R | 1 |
| Erdogan, D | 1 |
| Gullu, H | 1 |
| Caliskan, M | 1 |
| Yildirim, E | 1 |
| Bilgi, M | 1 |
| Ulus, T | 1 |
| Sezgin, N | 1 |
| Muderrisoglu, H | 2 |
| Demirbag, R | 1 |
| Yilmaz, R | 1 |
| Ulucay, A | 1 |
| Unlu, D | 1 |
| Ruggiero, C | 2 |
| Cherubini, A | 2 |
| Ble, A | 1 |
| Bos, AJ | 1 |
| Maggio, M | 2 |
| Dixit, VD | 1 |
| Lauretani, F | 2 |
| Bandinelli, S | 2 |
| Senin, U | 2 |
| Ferrucci, L | 2 |
| Ishizaka, Y | 1 |
| Toda, E | 1 |
| Hashimoto, H | 1 |
| Nagai, R | 1 |
| Yamakado, M | 1 |
| Ariel, RJ | 1 |
| Mellen, PB | 1 |
| Bleyer, AJ | 1 |
| Erlinger, TP | 1 |
| Evans, GW | 1 |
| Nieto, FJ | 1 |
| Wagenknecht, LE | 1 |
| Wofford, MR | 1 |
| Herrington, DM | 1 |
| Wei, YD | 1 |
| Hu, DY | 1 |
| Zhang, RF | 1 |
| Zheng, LQ | 1 |
| Li, J | 1 |
| Yu, JM | 1 |
| Xing, Y | 1 |
| Bianchi, C | 1 |
| Penno, G | 1 |
| Malloggi, L | 1 |
| Barontini, R | 1 |
| Corfini, M | 1 |
| Giovannitti, MG | 1 |
| Di Cianni, G | 1 |
| Del Prato, S | 1 |
| Miccoli, R | 1 |
| Hamed, SA | 1 |
| Hamed, EA | 1 |
| Hamdy, R | 1 |
| Nabeshima, T | 1 |
| Rajtar, R | 1 |
| Kloch, M | 1 |
| Bober, M | 1 |
| Kolasińska-Kloch, W | 1 |
| Maliavskaia, SI | 1 |
| Lebedev, AV | 1 |
| Ternovskaia, VA | 1 |
| Tseng, CH | 1 |
| Miller, E | 1 |
| Najjar, SS | 1 |
| Strazzullo, P | 1 |
| Puig, JG | 1 |
| Bozbas, H | 1 |
| Yildirir, A | 1 |
| Atar, I | 1 |
| Pirat, B | 1 |
| Eroglu, S | 1 |
| Aydinalp, A | 1 |
| Ozin, B | 1 |
| Wakabayashi, I | 1 |
| Masuda, H | 1 |
| Fukui, M | 1 |
| Tanaka, M | 1 |
| Shiraishi, E | 1 |
| Harusato, I | 1 |
| Hosoda, H | 1 |
| Asano, M | 1 |
| Kadono, M | 1 |
| Hasegawa, G | 1 |
| Yoshikawa, T | 1 |
| Nakamura, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Comparative Trial on the Effect of Febuxostat in Preventing Cerebral and Cardiorenovascular Events in Patients With Hyperuricemia[NCT01984749] | 1,000 participants (Anticipated) | Interventional | 2013-11-30 | Active, not recruiting | |||
| Effect of the Interaction Between Environmental Factors and Genetic Predisposition on Long-term Blood Pressure in Chinese Population[NCT02734472] | 5,298 participants (Anticipated) | Observational | 2016-07-31 | Recruiting | |||
| Effects of Allopurinol on Inflammatory Markers and Morphostructural Changes Evidenced by Musculoskeletal Ultrasound in Individuals With Asymptomatic Hyperuricemia. A Proof of Concept[NCT04012294] | Phase 3 | 200 participants (Anticipated) | Interventional | 2019-08-30 | Recruiting | ||
| The Effect of Allopurinol on Malondialdehyde, Nitric Oxide, Kidney Injury Molecule-1 Urine Levels, Resistive Index and Renal Elastography in Kidney Stone Patients After Extra Corporeal Shockwave Lithotripsy[NCT05414669] | Phase 4 | 35 participants (Actual) | Interventional | 2020-08-06 | Completed | ||
| Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
| [NCT02797028] | Phase 4 | 320 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | ||
| Assessing the Role of the NLRP3 Inflammasome in Driving Inflammation in Affected Joints of Patients With Intercritical Gout[NCT04125459] | 8 participants (Anticipated) | Observational | 2020-01-22 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for uric acid and Atherosclerosis
| Article | Year |
|---|---|
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Topics: Animals; Atherosclerosis; Comorbidity; Diabetes Mellitus, Type 2; Gout; Humans; Hypertension; Hyperu | 2021 |
Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.
Topics: Atherosclerosis; Cardiovascular Diseases; Female; Humans; Hyperuricemia; Male; Renal Insufficiency, | 2022 |
[Novel options to maximize oral lipid lowering treatment : Role of bempedoic acid in combination treatment].
Topics: Anticholesteremic Agents; Atherosclerosis; Cholesterol, LDL; Cross-Sectional Studies; Dicarboxylic A | 2022 |
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?
Topics: Atherosclerosis; Diabetes Mellitus, Type 2; Humans; Hypertension; Hyperuricemia; Purines; Reactive O | 2022 |
Serum Uric Acid Levels and Subclinical Atherosclerosis: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Topics: Adult; Atherosclerosis; Brazil; Carotid Intima-Media Thickness; Female; Humans; Longitudinal Studies | 2023 |
Serum Uric Acid Levels and Subclinical Atherosclerosis: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Topics: Adult; Atherosclerosis; Brazil; Carotid Intima-Media Thickness; Female; Humans; Longitudinal Studies | 2023 |
Serum Uric Acid Levels and Subclinical Atherosclerosis: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Topics: Adult; Atherosclerosis; Brazil; Carotid Intima-Media Thickness; Female; Humans; Longitudinal Studies | 2023 |
Serum Uric Acid Levels and Subclinical Atherosclerosis: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Topics: Adult; Atherosclerosis; Brazil; Carotid Intima-Media Thickness; Female; Humans; Longitudinal Studies | 2023 |
Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence.
Topics: Atherosclerosis; Endothelial Cells; Humans; Hyperuricemia; Uric Acid; Xanthine Oxidase | 2021 |
Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
Topics: Animals; Atherosclerosis; Biomarkers; Cell Proliferation; Endoplasmic Reticulum Stress; Endothelium, | 2017 |
Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases.
Topics: Animals; Arteries; Atherosclerosis; Calcium; Crystallization; Humans; Kidney; Kidney Calculi; Lipids | 2018 |
Hyperuricemia and endothelial function: From molecular background to clinical perspectives.
Topics: Antioxidants; Atherosclerosis; Cardiovascular Diseases; Catalysis; Endothelium, Vascular; Humans; Hy | 2018 |
Association of serum uric acid and metabolic syndrome in type 2 diabetes.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cross-Section | 2014 |
Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.
Topics: Adipocytes; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Differentiation; Cell Movement; | 2014 |
[The First Step Aiming at the Prevention of Hypertension and Atherosclerosis. Identification of Individuals at High Risk of Hypertension].
Topics: Albuminuria; Ankle Brachial Index; Atherosclerosis; Biomarkers; Blood Pressure; Cardiovascular Disea | 2015 |
Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis.
Topics: Animals; Atherosclerosis; Disease Progression; Free Radicals; Heart Failure; Humans; Inflammasomes; | 2016 |
Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.
Topics: Atherosclerosis; Gout; Humans; Hyperuricemia; Inflammasomes; Lipid Metabolism; Lipids; Oxidative Str | 2010 |
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Topics: Allopurinol; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; | 2012 |
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Topics: Allopurinol; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; | 2012 |
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Topics: Allopurinol; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; | 2012 |
Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Topics: Allopurinol; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; | 2012 |
[HYPERURICEMIA AND ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Blood; Cerebrovascular Disorders; Coronary Disease; Gout; Humans; | 1964 |
[The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
Topics: Animals; Atherosclerosis; Biomarkers; Causality; Clinical Trials as Topic; Comorbidity; Fibrin Fibri | 2006 |
Uric acid and oxidative stress: relative impact on cardiovascular risk?
Topics: Atherosclerosis; Biomarkers; Cardiovascular Diseases; Humans; Hyperuricemia; Oxidative Stress; React | 2007 |
7 trials available for uric acid and Atherosclerosis
| Article | Year |
|---|---|
Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: a subanalysis of the PRIZE study.
Topics: Ankle Brachial Index; Atherosclerosis; Awards and Prizes; Carotid Artery Diseases; Enzyme Inhibitors | 2022 |
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
Topics: Atherosclerosis; C-Reactive Protein; Febuxostat; Female; Humans; Hyperuricemia; Inflammation; Male; | 2023 |
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis.
Topics: Antihypertensive Agents; Atenolol; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Dihydro | 2019 |
The Effects of Allopurinol on the Carotid Intima-media Thickness in Patients with Type 2 Diabetes and Asymptomatic Hyperuricemia: A Three-year Randomized Parallel-controlled Study.
Topics: Adult; Aged; Allopurinol; Asian People; Atherosclerosis; Biomarkers; Blood Pressure; C-Reactive Prot | 2015 |
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Carotid Artery, Common; Dose-Response Relationship, | 2016 |
Sex difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atherosclerosis; Blood Pressure; Body Mass Index; Cohor | 2007 |
Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cohort | 2007 |
117 other studies available for uric acid and Atherosclerosis
| Article | Year |
|---|---|
Sesamol supplementation alleviates nonalcoholic steatohepatitis and atherosclerosis in high-fat, high carbohydrate and high-cholesterol diet-fed rats.
Topics: Animals; Aorta; Atherosclerosis; Benzodioxoles; Cholesterol, Dietary; Diet, High-Fat; Dietary Carboh | 2021 |
Pleiotropic Effects of Functional
Topics: Adult; Atherosclerosis; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Mass Index; DNA Met | 2021 |
Protective Effect of Uric Acid on ox-LDL-Induced HUVECs Injury via Keap1-Nrf2-ARE Pathway.
Topics: Antioxidants; Atherosclerosis; Carboxylic Ester Hydrolases; Cell Adhesion; Cell Line, Tumor; Cells, | 2021 |
Increased Impact of Serum Uric Acid on Arterial Stiffness and Atherosclerosis in Females.
Topics: Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Female; Humans; Male; Middle Aged | 2022 |
Age and Gender Differences Between Carotid Intima-Media Thickness and Serum Uric Acid.
Topics: Adult; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; F | 2022 |
Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis.
Topics: Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Carotid Stenosis; Choleste | 2022 |
High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2-Mediated Autophagy Dysfunction and Ferroptosis.
Topics: Animals; Atherosclerosis; Autophagy; Ferroptosis; Hyperuricemia; Mice; NF-E2-Related Factor 2; Plaqu | 2022 |
Association of Hyperuricemia with 10-Year Atherosclerotic Cardiovascular Disease Risk among Chinese Adults and Elders.
Topics: Adult; Aged; Atherosclerosis; Cardiovascular Diseases; China; Cross-Sectional Studies; Female; Human | 2022 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy.
Topics: Animals; Apoptosis; Atherosclerosis; Autophagy; Mice; Mice, Knockout; Plaque, Atherosclerotic; Uric | 2023 |
The Relationship between Uric Acid/Albumin Ratio and Carotid Intima-Media Thickness in Patients with Hypertension.
Topics: Atherosclerosis; C-Reactive Protein; Carotid Intima-Media Thickness; Humans; Hypertension; Inflammat | 2023 |
Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats.
Topics: Animals; Antioxidants; Atherosclerosis; Diet, High-Fat; Enzyme Inhibitors; Febuxostat; Lipids; Non-a | 2023 |
Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS/NLRP3 pathway.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Human Umbilical Vein Endothelial Cells; Humans; Hyperur | 2023 |
Association of Empirical Dietary Atherogenic Indices with All-Cause and Cause-Specific Mortality in a Multi-Ethnic Adult Population of the United States.
Topics: Apolipoprotein B-100; Atherosclerosis; Biomarkers; Cause of Death; Diet, Atherogenic; Feeding Behavi | 2019 |
Association between atherogenic index of plasma and subclinical renal damage over a 12-year follow-up: Hanzhong adolescent hypertension study.
Topics: Adolescent; Atherosclerosis; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hypertensio | 2020 |
Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation.
Topics: Adult; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Benzbromarone; Biomarkers; Disease M | 2020 |
Association between uric acid and brachial-ankle pulse wave velocity: secondary analysis of data from a cross-sectional study.
Topics: Adult; Ankle Brachial Index; Atherosclerosis; Biomarkers; Cross-Sectional Studies; Female; Humans; I | 2020 |
Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort.
Topics: Aged; Atherosclerosis; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Humans; Middle Aged | 2020 |
Clinical relevance of serum uric acid and abdominal aortic-calcification in a national survey.
Topics: Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Biomarkers; China; Female; Humans; Hyperuricemia | 2020 |
Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance.
Topics: Adult; Atherosclerosis; Biomarkers; C-Reactive Protein; Essential Hypertension; Female; Humans; Insu | 2020 |
Association between uric acid and atherosclerosis in community-dwelling older people: The SONIC study.
Topics: Aged; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cross-Sectional Stud | 2021 |
Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin.
Topics: Acne Vulgaris; Atherosclerosis; Cholesterol, HDL; Humans; Isotretinoin; Lipoproteins, HDL; Monocytes | 2021 |
Cameroonian professional soccer players and risk of atherosclerosis.
Topics: Adolescent; Adult; Antioxidants; Atherosclerosis; Athletes; Autoantibodies; Cameroon; Cholesterol, L | 2017 |
Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
Topics: Adult; Arthritis, Rheumatoid; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Intima-M | 2017 |
Aerobic Exercise for a Duration of 90 min or Longer Per Week may Reduce the Atherogenic Index of Plasma.
Topics: Atherosclerosis; Blood Glucose; Blood Pressure; Body Mass Index; China; Cross-Sectional Studies; Exe | 2018 |
Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?
Topics: Adult; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Female; Humans; Insulin; Leptin; | 2018 |
Allantoin as an independent marker associated with carotid intima-media thickness in subclinical atherosclerosis.
Topics: Allantoin; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Double-Blind Method; Humans; | 2018 |
Serum uric acid and arterial hypertension-Data from Sephar III survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickn | 2018 |
A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Female; Homocysteine; Humans; Hyperhomocystei | 2018 |
Can high uric acid levels be an independent risk factor for acute ischemic stroke due to large-artery atherosclerosis?
Topics: Atherosclerosis; Bilirubin; Biomarkers; Brain Ischemia; Carotid Intima-Media Thickness; Carotid Sten | 2018 |
Serum uric acid in asymptomatic adults is weakly associated with carotid artery FDG uptake but not intima-media thickness.
Topics: Adult; Asymptomatic Diseases; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Cro | 2020 |
Relationship Between Uric Acid, Proteinuria, and Atherogenic Index of Plasma in Renal Transplant Patients.
Topics: Adult; Aged; Atherosclerosis; Cardiovascular Diseases; Cohort Studies; Female; Glomerular Filtration | 2018 |
Association of ideal cardiovascular health metrics with serum uric acid, inflammation and atherogenic index of plasma: A population-based survey.
Topics: Adult; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female | 2019 |
Effect of uric acid serum levels on carotid arterial stiffness and intima-media thickness: A high resolution Echo-Tracking Study.
Topics: Adult; Aged; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Female; Humans; Hype | 2019 |
Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Intima-Media Thickness; C | 2019 |
Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals.
Topics: Adult; Aldosterone; Ankle Brachial Index; Atherosclerosis; Biomarkers; Carotid Intima-Media Thicknes | 2019 |
Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis.
Topics: Adult; Arteries; Asian People; Atherosclerosis; Cohort Studies; Constriction, Pathologic; Female; Hu | 2019 |
Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Atherosclerosis; Genetic Variation; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Ur | 2019 |
A primary estimation of the cardiometabolic risk by using artificial neural networks.
Topics: Adolescent; Adult; Age Factors; Aged; Atherosclerosis; Blood Pressure; Body Mass Index; Female; Fibr | 2013 |
Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
Topics: Adolescent; Adult; Age Factors; Atherosclerosis; Biomarkers; Body Mass Index; Coronary Artery Diseas | 2013 |
Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study.
Topics: Adult; Atherosclerosis; Female; Humans; Hypertension; Italy; Male; Metabolic Syndrome; Middle Aged; | 2014 |
High prevalence and risk factors for kidney dysfunction in patients with atherosclerotic cardio-cerebrovascular disease.
Topics: Age Factors; Aged; Aged, 80 and over; Atherosclerosis; Cerebrovascular Disorders; China; Coronary Di | 2014 |
Hyperuricaemia: the unintended consequence of insulin resistance/compensatory hyperinsulinaemia. Philanthropy gone awry.
Topics: Atherosclerosis; Coronary Artery Disease; Female; Humans; Male; Uric Acid | 2014 |
Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus.
Topics: Adult; Age Factors; Atherosclerosis; C-Reactive Protein; Carotid Arteries; China; Cross-Sectional St | 2014 |
Relationship between cardiovascular risk factors and the echogenicity and pattern of the carotid intima-media complex in men.
Topics: Adult; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Carotid | 2014 |
Increased circulating inflammatory markers may indicate that formula-fed children are at risk of atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Breast Feeding; Chemokine CCL2; Child, Preschool; Female; Humans; Infan | 2014 |
The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study.
Topics: Adult; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-S | 2014 |
Epilepsy and antiepileptic drugs: risk factors for atherosclerosis.
Topics: Adult; Analysis of Variance; Anticonvulsants; Atherosclerosis; C-Reactive Protein; Carotid Intima-Me | 2015 |
[Detection of early markers of atherosclerosis in men with various levels of risk of cardiovascular complications].
Topics: Adult; Ankle Brachial Index; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Arteries; | 2014 |
[Proaterogenic metabolic disorders in patients with chronic kidney disease nondiabetic origin: possibility of statin therapy].
Topics: Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Blood Pressure; Cardiotonic Agents; Disease | 2014 |
Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels.
Topics: Apolipoproteins; Atherosclerosis; Demography; Female; Genetic Association Studies; Humans; Least-Squ | 2014 |
Soluble ligand CD40 and uric acid as markers of atheromatosis in patients with obstructive sleep apnea.
Topics: Adult; Atherosclerosis; Biomarkers; Case-Control Studies; CD40 Ligand; Female; Humans; Hypertension; | 2015 |
Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling.
Topics: Animals; Atherosclerosis; Cell Adhesion; Cell Adhesion Molecules; Cell Survival; Chemokine CCL2; Che | 2015 |
Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes.
Topics: Aged; Asian People; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross- | 2015 |
Association of interleukin-10 promoter region polymorphisms with risk factors of Atherosclerosis.
Topics: Atherosclerosis; Blood Pressure; Carotid Intima-Media Thickness; Cholesterol; Female; Homocysteine; | 2015 |
The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Female; Humans; Male; Middle Aged; Progn | 2015 |
[Atypical risk factors of atherosclerosis in patients with hypothyroidism].
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Body Mass Index; C-Reactive Protein; Carotid Arteries; Fem | 2013 |
Impact of the Serum Uric Acid Level on Subclinical Atherosclerosis in Middle-aged and Elderly Chinese.
Topics: Adult; Age Factors; Aged; Asian People; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Caroti | 2015 |
High Uric Acid Levels During Pregnancy Linked to Increased Risk for Future Atherosclerotic-Related Hospitalization.
Topics: Adult; Atherosclerosis; Case-Control Studies; Female; Hospitalization; Humans; Israel; Pregnancy; Pr | 2015 |
Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Biomarkers; Bipolar Disorder; Blood Glucose; Body Mass Ind | 2015 |
Risk Factors for Subclinical Atherosclerosis and Uric Acid.
Topics: Asian People; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Female; Huma | 2015 |
Risk Factors for Subclinical Atherosclerosis and Uric Acid--Reply.
Topics: Asian People; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Female; Huma | 2015 |
Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study.
Topics: Atherosclerosis; Female; Humans; Male; Middle Aged; Nephrolithiasis; Prospective Studies; Renal Insu | 2015 |
Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus.
Topics: Adult; Aged; Arteries; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies | 2016 |
Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model.
Topics: Animals; Antihypertensive Agents; Aorta; Atherosclerosis; Blotting, Western; Disease Models, Animal; | 2015 |
Gout in Older Adults: The Atherosclerosis Risk in Communities Study.
Topics: Age Factors; Aged; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Bin | 2016 |
Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women.
Topics: Aged; Atherosclerosis; Blood Glucose; Blood Pressure; Cameroon; Cardiovascular Diseases; Cholesterol | 2016 |
Antihyperglycemic and antidiabetic effects of Ethyl (S)-2-(1-cyclohexylsulfamide carbamoyloxy) propanoate in streptozotocin-induced diabetic Wistar rats.
Topics: Animals; Atherosclerosis; Bilirubin; Blood Glucose; Body Weight; Carbamates; Creatinine; Diabetes Me | 2016 |
Iterative Outlier Removal: A Method for Identifying Outliers in Laboratory Recalibration Studies.
Topics: Atherosclerosis; Calibration; Clinical Laboratory Techniques; Data Interpretation, Statistical; Huma | 2016 |
Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
Topics: Atherosclerosis; Biomarkers; Female; Gout; Humans; Middle Aged; Prospective Studies; Risk Factors; U | 2016 |
Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ.
Topics: Angiotensin II; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Proliferation; Gene Expressi | 2017 |
Serum Total Sialic Acid Level is Elevated in Hypothyroid Patients as an Atherosclerotic Risk Factor.
Topics: Adolescent; Adult; Atherosclerosis; Autoantibodies; Biomarkers; C-Reactive Protein; Cardiovascular D | 2017 |
Atherogenic Index of Plasma Predicts Hyperuricemia in Rural Population: A Cross-Sectional Study from Northeast China.
Topics: Adult; Atherosclerosis; China; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Middle | 2016 |
Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia.
Topics: Acute Disease; Aged; Atherosclerosis; Cause of Death; Female; Heart Failure; Humans; Hyperuricemia; | 2017 |
Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid.
Topics: Adult; Atherosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Depressive Disorder; F | 2017 |
Clinical usefulness of metabolic risk factors to identify young asymptomatic women adults with subclinical atherosclerosis: A cross-sectional study.
Topics: Adult; Atherosclerosis; Blood Glucose; Carotid Intima-Media Thickness; Cross-Sectional Studies; Fema | 2017 |
Apple polyphenols and fibers attenuate atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Antioxidants; Apolipoproteins E; Atherosclerosis; Dietary Fiber; Flavonoids; Fruit; Lipids; | 2008 |
High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles.
Topics: Adult; Atherosclerosis; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; | 2009 |
Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease.
Topics: Adult; Aged; Arthritis, Psoriatic; Atherosclerosis; Biomarkers; Carotid Arteries; Cohort Studies; Fe | 2009 |
Edible mushroom Agaricus sylvaticus can prevent the onset of atheroma plaques in hipercholesterolemic rabbits.
Topics: Agaricus; Animals; Antioxidants; Aorta; Atherosclerosis; Cholesterol, Dietary; Hypercholesterolemia; | 2008 |
Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.
Topics: Antiparkinson Agents; Atherosclerosis; Biomarkers; Black or African American; Cohort Studies; Commun | 2009 |
Role of asymptomatic hyperuricemia and serum uric acid levels in the pathogenesis of subclinical atherosclerosis in psoriatic arthritis: comment on the article by Chen et al.
Topics: Arthritis, Psoriatic; Atherosclerosis; Cohort Studies; Comorbidity; Female; Humans; Hyperuricemia; M | 2009 |
Sex and age interaction with genetic association of atherogenic uric acid concentrations.
Topics: Age Factors; Aged; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Bin | 2010 |
Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.
Topics: Adult; Arteries; Atherosclerosis; Cross-Sectional Studies; Female; Humans; Lupus Erythematosus, Syst | 2010 |
Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study.
Topics: Adult; Age Factors; Aged; Atherosclerosis; Cardiomegaly; Cross-Sectional Studies; Female; Humans; Hy | 2010 |
Association of homocysteine with traditional and non-traditional risk factors in patients with atherosclerotic vascular disease.
Topics: Atherosclerosis; C-Reactive Protein; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk F | 2011 |
Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity.
Topics: Adiponectin; Adolescent; Atherosclerosis; Biomarkers; Calcium; Carotid Arteries; Child; Cholesterol, | 2011 |
Oxidative stress and endothelin-1 in atherosclerotic renal artery stenosis and effects of renal angioplasty.
Topics: Aged; Angioplasty; Atherosclerosis; Biomarkers; Endothelin-1; Female; Humans; Hypertension; Male; Mi | 2011 |
Risk profile in chronic kidney disease stage 3: older versus younger patients.
Topics: Age Factors; Aged; Aged, 80 and over; Albuminuria; Atherosclerosis; Cardiovascular Diseases; Diabeti | 2011 |
Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men.
Topics: Atherosclerosis; Biomarkers; Body Mass Index; Calcinosis; Carotid Intima-Media Thickness; Coronary A | 2012 |
Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
Topics: Albuminuria; Atherosclerosis; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic | 2012 |
Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Atherosclerosis; Blood Glucose; Carbamazepine; Carotid Art | 2012 |
Uric acid is an important predictor for hypertensive early atherosclerosis.
Topics: Adult; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Intima-Media Thick | 2012 |
Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Carot | 2012 |
[Uric acid, atherosclerosis and vascular calcifications in chronic kidney disease].
Topics: Adolescent; Adult; Aged; Atherosclerosis; Calcinosis; Cardiovascular Diseases; Chronic Disease; Como | 2012 |
[Clinical significance of insulin resistance syndrome in development of endothelial dysfunction in patients with primary gout].
Topics: Adult; Atherosclerosis; Blood Glucose; Brachial Artery; Carbohydrate Metabolism; Disease Progression | 2012 |
Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.
Topics: Adult; Age Factors; Asymptomatic Diseases; Atherosclerosis; Biomarkers; Body Mass Index; Cardiovascu | 2012 |
Biochemical indicators of atherogenic and protective activity of xydiphone in experimental animals.
Topics: Alkaline Phosphatase; Animals; Atherosclerosis; Biomarkers; Cholesterol, LDL; Creatine Kinase; Creat | 2012 |
Serum uric acid: marker for atherosclerosis as it is positively associated with "atherogenic index of plasma".
Topics: Adult; Atherosclerosis; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Humans; India | 2013 |
Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis.
Topics: Adult; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Ar | 2013 |
Synergistic effects of serum uric acid and cardiometabolic risk factors on early stage atherosclerosis: the cardiometabolic risk in Chinese study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; China; Female; Heart; Human | 2012 |
[Hepatocatalase: biochemical and pharmacological properties. Its relation with atherosclerosis].
Topics: Arteriosclerosis; Atherosclerosis; Catalase; Cholesterol; Granuloma; Humans; Uric Acid | 1963 |
"ATROMID" IN ATHEROSCLEROSIS.
Topics: Androsterone; Angina Pectoris; Arteriosclerosis Obliterans; Atherosclerosis; Blood Chemical Analysis | 1964 |
[BLOOD CHOLESTEROL AND TRIGLYCERIDES IN 2 OCCUPATIONAL GROUPS. FIRST RESULTS OF AN EPIDEMIOLOGIC INVESTIGATION ON THE FACTORS OF ATHEROSCLEROSIS].
Topics: Adolescent; Aging; Arteriosclerosis; Atherosclerosis; Blood; Blood Pressure; Body Weight; Cholestero | 1964 |
Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects.
Topics: Adult; Ankle; Atherosclerosis; Blood Flow Velocity; Blood Pressure; Brachial Artery; C-Reactive Prot | 2005 |
Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.
Topics: Adult; Aorta, Thoracic; Atherosclerosis; Brachial Artery; Carotid Artery, Common; Endothelium, Vascu | 2005 |
The inverse relationship between thoracic aortic intima media thickness and testosterone level.
Topics: Adult; Aged; Aorta, Thoracic; Atherosclerosis; C-Reactive Protein; Echocardiography, Transesophageal | 2005 |
Uric acid and inflammatory markers.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; C-Reactive Protein; Cytokines; Female; Humans; | 2006 |
Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals.
Topics: Aged; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Artery Diseases; Elasticity; Femal | 2007 |
Significance of uric acid for the heart and vessels.
Topics: Atherosclerosis; Biomarkers; Humans; Uric Acid | 2006 |
Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study.
Topics: Atherosclerosis; Black or African American; Cohort Studies; Female; Follow-Up Studies; Humans; Hyper | 2006 |
[Metabolic syndrome complicated by peripheral arterial disease: clinical study of 2115 cases].
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Blood Glucose; Blood Urea Nitrogen; Body Mass Index | 2006 |
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Topics: Aged; Atherosclerosis; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease | 2008 |
Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy.
Topics: Adult; Anticonvulsants; Antioxidants; Atherosclerosis; Blood Glucose; Carotid Arteries; Cholesterol; | 2007 |
[Chronic asymptomatic hyperuricemia as a marker of atherogenic risk in children].
Topics: Adolescent; Age Factors; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Chi-Square Dist | 2007 |
Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification.
Topics: Age Factors; Aged; Aged, 80 and over; Aortic Valve; Atherosclerosis; C-Reactive Protein; Calcinosis; | 2007 |
Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Atherosclerosis; Biomarkers; Body Mass Index; Carotid A | 2009 |
Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemo | 2008 |